structure. In the case of the knee and hand, some component of that organ we call a joint may be involved, be it synovium, bone, capsule, or other structure. Page 9 line 211: Morphologic effects as seen on imaging would be, by their very nature, long term, over years. Discussion in general: Suggest discussing the safety of PEMF overall given the wide range of applications such as fracture healing. Also, even if the information is not available, a discussion of the difference fields used would be useful.
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GENERAL COMMENTS
This meta-analysis aims to assess the efficacy and safety of the pulsed electromagnetic field therapy in treating osteoarthritis using information from randomized controlled trials. This analysis suggests that PEMF could alleviate pain and improve physical function for knee OA. The strengths of the study are the methodology and clear presentation of information.
Major comments
The study has some aspects to improve: -Authors could limit their conclusions to knee OA -PEMF effect on pain of hand OA of one clinical trial should not be reported as results in the meta-analysis. This finding on hand OA could be only part of the introduction or discussion.
Minor comments 1) Introduction: page 5, line 70, please define PES.
2) Methods: Please specify in page 6, line 105, that adverse events were your safety outcome. p.9 Conclusion is concise and understandable, covers the gist of the article. However, given that people will often read just the abstract and conclusion, it might be worth noting in the conclusion that not enough sample size was available for OA.
REVIEWER
In the tables, the numbers look well-reported. However, I am curious if the authors performed a subgroup analysis on the number of treatments. No such report was available in the article, the authors reported a different type of subgroup analysis. Many of the articles had 3 or 6 weeks of sessions, for 15-18 sessions. However, others had 84 sessions in six weeks or 30 sessions. Was there a subgroup comparison done between high rate of treatment and low rate of treatment? Did the number of treatments make a difference like the length of time made a difference? I know they ran overall heterogeneity, but I did not see the information on analysis of the number of treatments in the data.
VERSION 1 -AUTHOR RESPONSE
Replies to Editors: Comment 1: This was quite a straightforward paper; they cite all the relevant reviews and an update is warranted since the last review by Ryang et al is from 2013. The authors should be able to address all the queries. What transpires from the reviews is that there is perhaps too much prominence given to the hand and cervical osteoarthritis findings when there is just 1 study from hand OA and 1-2 studies for cervical OA, so that should be toned down particularly in the abstract. One of the reviewers even suggests just focusing this review on knee OA only but I think it is probably enough to stress that the hand and cervical OA findings may not be robust enough to inform practice.
Response: Thank you so much for your professional comments.
Comment 2:
Please include the original protocol for the study, if one exists, as a supplementary file.
Response:
We did not register the protocol, but we conducted this meta-analysis according to a predesigned protocol. Please also specify whether articles not in English language were included. Please also specify if the three trials excluded because the full text could not be obtained were RCTs.
Response: (1) The word "irrelevant" in the flow diagram including the following aspects: no relevant population, no relevant control, no relevant outcomes. Besides, the word "not OA" means non-OA diseases, and it was classed as "no relevant population" now. And studies involving non PEMF therapy was classed as "no relevant control" now. We have modified some details in the flow chart to avoid misunderstanding.
(2) Studies included in this meta-analysis were not restricted to English language articles.
(3) Three RCTs were excluded because full-text were not available. We have tried to get the full-text through sending an email to corresponding author of each article. Regrettably, we still have not gotten full-text of these three RCTs. Response: This issue has been considered in the design of the research protocol, and we have tried to extract relevant data. However, because the number of studies reporting the pulse frequency of PEMF application, pulse intensity and other parameters of PEMF was very limited, we did not conduct a subgroup analysis according to these parameters of PEMF. We have added this issue to the limitation of this study. Comment 8: Page 6 line 127: Albeit time is important, the actual signal has an effect. What was the carrier frequency (when that applies), the intensity, duration of pulse, and duty cycle when that applies?
Response: This issue has been considered in the design of the research protocol, and we have tried to extract relevant data. However, because the number of studies reporting the pulse intensity, duration of pulse, and duty cycle of PEMF was very limited, we did not conduct a subgroup analysis according to these parameters of PEMF. We have added this issue to the limitation of this study.
(Page 10 line 226-228) 
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Comment 11: Page 9 line 198: I think that one of the key variables for the neck is that the pain may not be face joint pain, but from some other structure. In the case of the knee and hand, some component of that organ we call a joint may be involved, be it synovium, bone, capsule, or other structure.
Response:
We agree with your points. In fact, the points presented in our manuscript is similar to yours. Different components between different organs may be one of the reasons that affect the symptoms and treatment efficacy of OA in different sites.
Comment 12: Page 9 line 211: Morphologic effects as seen on imaging would be, by their very nature, long term, over years.
Response: Thank you for your comment. Morphological effects are meaningful in assessing the therapeutic effects of OA, but it requires longer observation intervals and more effort than pain and function outcomes. However, the follow-up time of the included studies was relatively short and no observation was made. Future researches could focus on this area.
Comment 13: Discussion in general: Suggest discussing the safety of PEMF overall given the wide range of applications such as fracture healing. Also, even if the information is not available, a discussion of the difference fields used would be useful. 
Comment 14: Major comments
The study has some aspects to improve: -Authors could limit their conclusions to knee OA -PEMF effect on pain of hand OA of one clinical trial should not be reported as results in the metaanalysis. This finding on hand OA could be only part of the introduction or discussion.
Response: Thank you for your professional suggestions. Because the number of clinical trial focusing on hand or cervical OA is limited, the hand and cervical OA findings may not be robust enough to inform practice. We have made some modifications of our conclusions. In the other hand, because OA is a multi-joint disease. We considered that it is also meaningful to include all joints that have been studied in previous trials. Response: We chose the sham treatment group as a control group rather than a blank group because of the following reasons. Firstly, it is difficult to achieve double-blind in a blank control group, which may reduce the quality of the study. Secondly, if a blank control group is selected, the influence caused by the placebo effect cannot be ruled out. For the above two reasons, we chose the shamcontrolled group. Comment 26: p.9 Conclusion is concise and understandable, covers the gist of the article. However, given that people will often read just the abstract and conclusion, it might be worth noting in the conclusion that not enough sample size was available for OA. Response: Thank you for your great suggestions. Some studies showed that short-time treatment may be more effective than long-time, [1] so we put more attention to it. Regarding the rate of treatment, we must to say it is really important to clinical practice as you suggested. However, significant heterogeneity exists among trials included in this study, for example, 30 sessions were completed within 6 weeks in one trial and 84 sessions were completed within the same duration in another trial, 15 sessions were completed within 3 weeks in one trial and 30 sessions were completed within 4 weeks in another trial. Therefore, the significance of its implication may be attenuated, so we did not do a subgroup analysis in the present study.
